Literature DB >> 20727394

Folding domains within the ricin toxin A subunit as targets of protective antibodies.

Joanne M O'Hara1, Lori M Neal, Elizabeth A McCarthy, Jane A Kasten-Jolly, Robert N Brey, Nicholas J Mantis.   

Abstract

Efforts to develop an effective vaccine against ricin are focused on the engineering of attenuated and stable recombinant forms of the toxin's enzymatic A subunit (RTA). While several candidate antigens are in development, vaccine design and efficacy studies are being undertaken in the absence of a fundamental understanding of those regions of RTA that are critical in eliciting protective immunity. In this present study, we produced and characterized a collection of monoclonal antibodies (MAbs) directed against five distinct immunodominant regions on RTA, and used these MAbs to identify several key neutralizing epitopes on the toxin. Protective MAbs were directed against α-helices located in RTA folding domains 1 and 2, whereas non-neutralizing antibodies recognized random coils and loops that were primarily confined to folding domain 3. These data offer insights into the immunodominant and structural determinants on RTA that give rise to protective immunity, and for the first time provide an immunological rationale for ricin vaccine design.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727394      PMCID: PMC2954487          DOI: 10.1016/j.vaccine.2010.08.020

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  42 in total

1.  Prediction of a conserved, neutralizing epitope in ribosome-inactivating proteins.

Authors:  F J Lebeda; M A Olson
Journal:  Int J Biol Macromol       Date:  1999-01       Impact factor: 6.953

Review 2.  Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin.

Authors:  Nicholas J Mantis
Journal:  Adv Drug Deliv Rev       Date:  2005-06-17       Impact factor: 15.470

3.  A semi-empirical method for prediction of antigenic determinants on protein antigens.

Authors:  A S Kolaskar; P C Tongaonkar
Journal:  FEBS Lett       Date:  1990-12-10       Impact factor: 4.124

4.  Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin.

Authors:  Joan E Smallshaw; James A Richardson; Seth Pincus; John Schindler; Ellen S Vitetta
Journal:  Vaccine       Date:  2005-09-15       Impact factor: 3.641

5.  Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol.

Authors:  A Rapak; P O Falnes; S Olsnes
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 6.  Ricin poisoning: a comprehensive review.

Authors:  Jennifer Audi; Martin Belson; Manish Patel; Joshua Schier; John Osterloh
Journal:  JAMA       Date:  2005-11-09       Impact factor: 56.272

7.  Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo.

Authors:  P V Lemley; P Amanatides; D C Wright
Journal:  Hybridoma       Date:  1994-10

8.  Structure of ricin A-chain at 2.5 A.

Authors:  B J Katzin; E J Collins; J D Robertus
Journal:  Proteins       Date:  1991

9.  A pilot clinical trial of a recombinant ricin vaccine in normal humans.

Authors:  Ellen S Vitetta; Joan E Smallshaw; Elaine Coleman; Hasan Jafri; Callie Foster; Robert Munford; John Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

10.  The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins.

Authors:  Y Endo; K Mitsui; M Motizuki; K Tsurugi
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

View more
  50 in total

1.  Recent advances in the development of vaccines against ricin.

Authors:  Robert N Brey; Nicholas J Mantis; Seth H Pincus; Ellen S Vitetta; Leonard A Smith; Chad J Roy
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

2.  Using homology modeling to interrogate binding affinity in neutralization of ricin toxin by a family of single domain antibodies.

Authors:  Andrea Bazzoli; David J Vance; Michael J Rudolph; Yinghui Rong; Siva Krishna Angalakurthi; Ronald T Toth; C Russell Middaugh; David B Volkin; David D Weis; John Karanicolas; Nicholas J Mantis
Journal:  Proteins       Date:  2017-08-04

3.  Structural insights into the neutralization mechanism of monoclonal antibody 6C2 against ricin.

Authors:  Yuwei Zhu; Jianxin Dai; Tiancheng Zhang; Xu Li; Pengfei Fang; Huajing Wang; Yongliang Jiang; Xiaojie Yu; Tian Xia; Liwen Niu; Yajun Guo; Maikun Teng
Journal:  J Biol Chem       Date:  2013-07-12       Impact factor: 5.157

4.  Stepwise engineering of heterodimeric single domain camelid VHH antibodies that passively protect mice from ricin toxin.

Authors:  David J Vance; Jacqueline M Tremblay; Nicholas J Mantis; Charles B Shoemaker
Journal:  J Biol Chem       Date:  2013-11-07       Impact factor: 5.157

5.  Evaluation of lumazine synthase from Bacillus anthracis as a presentation platform for polyvalent antigen display.

Authors:  Yangjie Wei; Newton Wahome; Greta VanSlyke; Neal Whitaker; Prashant Kumar; Michael L Barta; Wendy L Picking; David B Volkin; Nicholas J Mantis; C Russell Middaugh
Journal:  Protein Sci       Date:  2017-09-13       Impact factor: 6.725

6.  Structural Analysis of Single Domain Antibodies Bound to a Second Neutralizing Hot Spot on Ricin Toxin's Enzymatic Subunit.

Authors:  Michael J Rudolph; David J Vance; Michael S Cassidy; Yinghui Rong; Nicholas J Mantis
Journal:  J Biol Chem       Date:  2016-11-30       Impact factor: 5.157

7.  Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activity.

Authors:  Michael J Rudolph; David J Vance; Simon Kelow; Siva Krishna Angalakurthi; Sophie Nguyen; Simon A Davis; Yinghui Rong; C Russell Middaugh; David D Weis; Roland Dunbrack; John Karanicolas; Nicholas J Mantis
Journal:  Protein Eng Des Sel       Date:  2018-07-01       Impact factor: 1.650

8.  Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice.

Authors:  Joanne M O'Hara; Robert N Brey; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2013-03-20

9.  Functional divergence between the two P1-P2 stalk dimers on the ribosome in their interaction with ricin A chain.

Authors:  Przemysław Grela; Xiao-Ping Li; Marek Tchórzewski; Nilgun E Tumer
Journal:  Biochem J       Date:  2014-05-15       Impact factor: 3.857

10.  Humanized Monoclonal Antibody That Passively Protects Mice against Systemic and Intranasal Ricin Toxin Challenge.

Authors:  Greta Van Slyke; Erin K Sully; Natasha Bohorova; Ognian Bohorov; Do Kim; Michael H Pauly; Kevin J Whaley; Larry Zeitlin; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.